Blog

TRAC, Canada and MedGenome announce a Cancer Immunotherapy solution – ETHealthworld.com


ETHealthworld.com

TRAC, Canada and MedGenome announce a Cancer Immunotherapy solution
ETHealthworld.com
July 20, 2017, Mumbai: Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against …

2017-07-20 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.